| ME THODS

| Data collection
In addition, follow-up times, ICD intracardiac recordings, and clinical outcomes were documented retrospectively from hospital records.
| Implantation
Standard transvenous ICD and CRT-D implantation were implemented. For the purpose of defibrillation coil positioning into the CS, a venogram of the CS was systematically performed in order to assess the presence of a ventricular branch with a sufficiently large diameter for cannulation. Subsequently, a sheath was placed, and through it, a wire (Wholey, Covidien, Plymouth, MN, USA) was advanced into the selected ventricular vein through a CS sheath. The sheath was advanced into the ventricular vein branch of choice so that its tip would be committed to the vein. We then advanced an ICD coil in the vein. This lead was connected to the proximal DF-1 port of the ICD. Finally, upper limit of vulnerability testing was conducted again.
| DFT testing
Ventricular fibrillation was induced via delivery of a 0.8 or 1 J T-wave shock. Upon detection of VF, a defibrillation shock of 25 J was delivered. If this shock failed to terminate VF, 25-35 J was delivered.
Successful defibrillation was documented upon termination of VF with the implanted device.
| Clinical follow-up
As a standard precautionary measure, all patients were hospitalized for at least 24-hours postimplantation. They underwent continuous telemetry monitoring, a 12-lead electrocardiogram, and a 24-hour ambulatory electrocardiography prior to discharge from the hospital. In the absence of symptoms or device therapy, patients were seen routinely every 3-6 months for clinical review and device interrogation. ICD information was retrieved through the device interrogation.
| Statistical analysis
Gaussian continuous variables are reported as mean ± SD and nonGaussian variables as Median [minimum-maximum]. Qualitative findings were described as numbers and percentages. All statistics were performed with the use of the SPSS software (SPSS v19, Armonk, NY, USA). All authors had full access to the data and take responsibility for its integrity. They have read and agreed to the manuscript as written.
| RE SULTS
Defibrillation threshold testing was performed in 96% of all patients referred for ICD implantation in a single tertiary center over a 6 year interval ( Of these, four patients presented with high DFT at implant despite polarity wave changes, tilt modifications, and more apical RV lead positioning (patients number 1-4 from Table 1 F I G U R E 2 Chest radiograph of cases 4-6, respectively, presented in Table 1 , showing the final position of the coronary sinus coil. Postero-anterior fluoroscopic view (A1; B1; C1; D1) and lateral fluoroscopic view (A2; B2; C2; D2)
F I G U R E 1 Chest radiograph of cases 1-3, respectively, presented in Table 1 , showing the final position of the coronary sinus coil. Postero-anterior fluoroscopic view (A1; B1; C1; D1) and lateral fluoroscopic view (A2; B2; C2; D2)
VF, and the first shock was delivered unanimously without delay.
Two patients underwent simultaneous LV lead implantation in a posterolateral branch of the CS for biventricular pacing (patients 2 and 3, Table 1 ; Figure 1B ,C).
Another two patients (patient 5, Figure 2B and patient 6, Table 1 
| D ISCUSS I ON
The present study demonstrates the efficacy of coil placement within the CS (as part of a dual-coil system) in patients with a high DFT or previously failed ICD shocks. Independent positioning of this coil in the CS can result in substantial reductions in the mean DFT and associates with optimal long-term stability.
| Pitfalls in currently available techniques
Normal DFT is usually measured at ≤15 J and often <10 J with biphasic shocks and improved lead systems. DFTs above 20 J commonly arise during ICD implantation. Every available alternative offers distinct advantages. However, each has its shortcomings as well, a factor that has precluded the generalizability of a standard bailout protocol. For instance, the addition of a coil in the azygos vein to lower the DFT has been described by a few operators. [14] [15] [16] However, it has proven to be highly time-consuming as it requires significant manipulation in order to manoeuvre a stiff defibrillation coil across many angles spanning from the brachiocephalic vein to the distal part of the azygos vein.
15
In previous reports, the use of an azygos coil effectively reduced the DFT to an acceptable level, an effect likely attributable to the addition of an antero-posterior defibrillation vector across the LV.
The use of a subcutaneous array, also effective in DFT reduction, requires additional skin incisions or tunneling, which similarly increase the complexity of the procedure.
| CS coil placement
In theory, placement of a coil in the CS should provide a feasible solution to the aforementioned hurdles. As is the case with azygos vein coil placement, CS placement adds an antero-posterior defibrillation vector across the LV. Moreover, the CS represents a more accessible structure than the azygos vein, one that does not require special equipment and can thus be accomplished expeditiously in the standard implant laboratory. Nevertheless, the technique raises concerns about possible hindrance of LV lead delivery in the event that a cardiac resynchronization therapy (CRT) device is required. In our limited experience, this issue did not represent a significant impediment in three patients who underwent LV lead placement for biventricular pacing simultaneously with the ICD coil implantation. Another plausible concern is contact between the CS coil and the LV lead, which may result in oversensing and inappropriate shocks. In our small cohort, the coil was consistently delivered out of contact with the LV lead, and no inappropriate shocks due to oversensing or interference with the LV lead ever took place.
Although it would have been attractive to use the defibrillation lead in the LV vein to pace the LV and minimize the hardware deployed in the CS, adequate LV capture was not achieved, and a separate lead was required for cardiac resynchronization.
Frequent ICD discharges may result in a secondary rise in DFT because of the fibrosis around the electrode tip. 17, 18 Despite multiple appropriate and inappropriate shocks within our cohort, no significant rise in DFT was noted on follow-up. Amiodarone treatment is also known to increase DFT slightly, 19 two patients in our cohort received amiodarone and there was no change in dosage following implantation in one of them. Finally, lead extraction is often a difficult task, one that none of our patients have required so far.
Subsequently, it remains to be seen whether an additional lead-array could be beneficial in the event of system extraction.
All in all, from our limited experience, the dual-coil system
with CS lead appears to be a safe and reliable bailout strategy.
Nevertheless, further studies with longer follow-up and larger patient cohorts are mandated in the establishment and widespread adoption of this technique.
| Limitations
The necessity and appropriateness of DFT testing often comes into question. Complications of DFT testing relate to: (a) prolonged VF when shocks fail, leading to myocardial ischemia and contractile dysfunction that can persist even after restoration of normal rhythm, particularly in preexisting CHF, and (b) direct electroporation damage to the myocardium due to repeated shocks. Both can lead to electromechanical dissociation and contractility dysfunction, and culminate in cardiogenic shock. This study does not attempt to confirm the efficacy of DFT testing as an appropriate tool in the optimization of ICD shocks. Rather, the study seeks to report on the feasibility of a bailout strategy for both patients with high DFT and those with failed ICD shocks. Nevertheless, multiple limitations in this study merit discussion. The study was retrospective and is subject to the inherent limitations of this study design.
In addition, study results were based on a relatively small number of cases with a limited follow-up period. Moreover, the study design lacks a randomized control group consisting of patients undergoing alternative bailout strategies. Finally, another important disadvantage of this approach is that the lead needs to be connected to the proximal DF-1 port of the ICD, with the subsequent discomfort for patient and operator as compared with the DF-4 connector.
The study must thus be regarded as a proof of the feasibility of a novel strategic approach. Its generalizability and widespread applicability must be assessed further in larger, systematic trials.
Moreover, until the safety of extraction can be established, this technique is probably best reserved for patients who may have very advanced disease and lack of other option.
| CON CLUS ION
Positioning of a defibrillation coil into the CS in patients with elevated DFT and those with failed ICD shocks is a feasible alternative, which can result in a substantial reduction in mean DFT and it is associates with optimal long-term stability.
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